Table 3.

Odds ratios of baseline continuous predictors on development of chemotherapy stoppages, infections, hospitalizations, and adverse events (n=18)

Predictor	Chemotherapy stoppage or reduction				Infection				Hospitalization				Adverse event
	2.5% LCL	97.5% UCL	OR	P	2.5% LCL	97.5% UCL	OR	P	2.5% LCL	97.5% UCL	OR	P	2.5% LCL	97.5% UCL	OR	P
Mental health	0.94	1.15	1.04	0.50	0.95	1.17	1.05	0.38	0.82	1.02	0.92	0.16	0.86	1.06	0.96	0.43
Physical health	0.75	1.07	0.91	0.29	0.90	1.27	1.06	0.50	0.89	1.24	1.04	0.63	0.88	1.23	1.03	0.69
Symptom severity	0.97	1.05	1.01	0.64	0.94	1.02	0.99	0.47	0.95	1.03	0.99	0.64	0.95	1.03	0.99	0.69
Symptom interference	0.97	1.04	1.00	0.83	0.96	1.03	1.00	0.86	0.96	1.04	1.00	0.95	0.96	1.04	1.00	0.98
BMI	1.01	1.47	1.19	0.06	0.86	1.13	0.99	0.83	0.84	1.11	0.97	0.66	0.82	1.09	0.95	0.48
HbA1c	0.66	5.15	1.61	0.33	0.87	9.17	2.26	0.15	0.66	5.15	1.61	0.33	0.65	6.47	1.67	0.35
Years with diabetes	0.79	1.04	0.93	0.26	1.00	1.38	1.13	0.10	0.87	1.09	0.98	0.71	0.99	1.47	1.15	0.15
Number of comorbidities	0.50	1.41	0.89	0.63	0.70	1.79	1.11	0.66	0.78	2.07	1.24	0.38	0.77	2.08	1.23	0.39

*Metric of ORs >1.5 or <0.5 or P<0.1 was used to identify continuous predictor variables that merit additional investigation. BMI: Body mass index, ORs: Odds ratios, HbA1c: Glycated hemoglobin, LCL: Lower confidence limit, UCL: Upper confidence limit